Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost vs Vehicle and Minoxidil in Female Pattern Hair Loss
2011-000380-27Phase 2Completed
- Sponsor
- Allergan
- Start
- Apr 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bimatoprost in Female Pattern Hair Loss (FPHL) and androgenetic alopecia (AGA) (5 arms), sponsored by Allergan. Primary endpoint: Target Area Hair Count. Started Apr 2011; status: completed.
02
Drugs
bimatoprost
03
Conditions
Female Pattern Hair Loss (FPHL)androgenetic alopecia (AGA)
Beyond the preview
Go deeper on 2011-000380-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000380-27.